Randomized controlled trialHumanClinical Trial, Phase III
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial
The Journal of clinical endocrinology and metabolism, 2020 Apr 1. Johannsson G, Gordon MB, Højby Rasmussen M and 6 others.
Study type
Randomized controlled trial · Clinical Trial, Phase III
Subjects
Human participants (PubMed MeSH: Humans)
Journal
The Journal of clinical endocrinology and metabolism
Published
2020 Apr 1
PubMed
Where PepCue cites this
This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.
Indexed under
MeSH terms assigned by the National Library of Medicine.
BiomarkersBody CompositionDose-Response Relationship, DrugDouble-Blind MethodDwarfism, PituitaryFemaleFollow-Up StudiesHormone Replacement TherapyHuman Growth HormoneHumansInsulin-Like Growth Factor IMale
Other papers on Human Growth Hormone
Systematic review / meta-analysis · 2010
Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation
Systematic review / meta-analysis · 2007Systematic review: the safety and efficacy of growth hormone in the healthy elderly
Journal article · 1990Effects of human growth hormone in men over 60 years old
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page